216 related articles for article (PubMed ID: 35215762)
21. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
22. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus (EBV) gene expression in interstitial pneumonitis in Brazilian human immunodeficiency virus-1-infected children: is EBV associated or not?
Toro AA; Altemani AM; da Silva MT; Morcillo AM; Vilela MM
Pediatr Dev Pathol; 2010; 13(3):184-91. PubMed ID: 19968485
[TBL] [Abstract][Full Text] [Related]
24. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study.
Chiereghin A; Piccirilli G; Belotti T; Prete A; Bertuzzi C; Gibertoni D; Gabrielli L; Turello G; Borgatti EC; Barbato F; Sessa M; Arpinati M; Bonifazi F; Lazzarotto T
Med Microbiol Immunol; 2019 Dec; 208(6):825-834. PubMed ID: 31289930
[TBL] [Abstract][Full Text] [Related]
26. Epidemiological and Liver Biomarkers Profile of Epstein-Barr Virus Infection and Its Coinfection with Cytomegalovirus in Patients with Hematological Diseases.
Ferrari de Freitas L; de Melo Silva J; Nogueira Barbosa A; Miranda Santos E; Pinheiro-Silva R; Soares Pontes G
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439817
[TBL] [Abstract][Full Text] [Related]
27. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
[TBL] [Abstract][Full Text] [Related]
28. Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR.
Dehee A; Asselot C; Piolot T; Jacomet C; Rozenbaum W; Vidaud M; Garbarg-Chenon A; Nicolas JC
J Med Virol; 2001 Nov; 65(3):543-52. PubMed ID: 11596092
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus load in children infected with human immunodeficiency virus type 1 in Uganda.
Petrara MR; Penazzato M; Massavon W; Nabachwa S; Nannyonga M; Mazza A; Gianesin K; Del Bianco P; Lundin R; Sumpter C; Zanchetta M; Giaquinto C; De Rossi A
J Infect Dis; 2014 Aug; 210(3):392-9. PubMed ID: 24550442
[TBL] [Abstract][Full Text] [Related]
30. Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.
Luderer R; Kok M; Niesters HG; Schuurman R; de Weerdt O; Thijsen SF
Mol Diagn; 2005; 9(4):195-200. PubMed ID: 16392898
[TBL] [Abstract][Full Text] [Related]
31. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
32. Assessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.
Shoman S; Nabil M; Tabl A; Ghanem H; Kafrawy SE
Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):722-7. PubMed ID: 25317700
[TBL] [Abstract][Full Text] [Related]
33. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
[TBL] [Abstract][Full Text] [Related]
34. Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
Cui J; Yan W; Xu S; Wang Q; Zhang W; Liu W; Ni A
PLoS One; 2018; 13(3):e0193171. PubMed ID: 29494658
[TBL] [Abstract][Full Text] [Related]
35. EBV renders B cells susceptible to HIV-1 in humanized mice.
McHugh D; Myburgh R; Caduff N; Spohn M; Kok YL; Keller CW; Murer A; Chatterjee B; Rühl J; Engelmann C; Chijioke O; Quast I; Shilaih M; Strouvelle VP; Neumann K; Menter T; Dirnhofer S; Lam JK; Hui KF; Bredl S; Schlaepfer E; Sorce S; Zbinden A; Capaul R; Lünemann JD; Aguzzi A; Chiang AK; Kempf W; Trkola A; Metzner KJ; Manz MG; Grundhoff A; Speck RF; Münz C
Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32576602
[TBL] [Abstract][Full Text] [Related]
36. Pivotal role of HIV and EBV replication in the long-term persistence of monoclonal gammopathy in patients on antiretroviral therapy.
Ouedraogo DE; Makinson A; Vendrell JP; Casanova ML; Nagot N; Cezar R; Bollore K; Al Taaba Y; Foulongne V; Badiou S; Viljoen J; Reynes J; Van de Perre P; Tuaillon E
Blood; 2013 Oct; 122(17):3030-3. PubMed ID: 23940281
[TBL] [Abstract][Full Text] [Related]
37. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F
J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
40. Cell reservoirs of the Epstein-Barr virus in biopsy-proven lymphocytic interstitial pneumonitis in HIV-1 subtype E infected children: identification by combined in situ hybridization and immunohistochemistry.
Bhoopat L; Rangkakulnuwat S; Okonogi R; Wannasai K; Bhoopat T
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):212-8. PubMed ID: 19801937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
